SCHEMBL7659541

SCHEMBL7659541

CSc1ccc(C(=O)Nc2ccc(C=Cc3ccc(NC(=O)c4ccc(S(C)(=O)=O)c([N+](=O)[O-])c4)cc3S(=O)(=O)O)c(S(=O)(=O)O)c2)cc1S(=O)(=O)N1CCOCC1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.54
ALDH1A1 P00352 7/20 0.54
LMNA P02545 7/20 0.54
MEN1 O00255 6/20 0.54
KMT2A Q03164 6/20 0.54
SMN1; SMN2 Q16637 6/20 0.54
MAPK1 P28482 3/20 0.54
HTT P42858 3/20 0.54
GAA P10253 2/20 0.49
USP2 O75604 1/20 0.46
TSHR P16473 1/20 0.45
MITF O75030 2/20 0.44
CNR2 P34972 2/20 0.44
CNR1 P21554 1/20 0.44
TP53 P04637 1/20 0.44
PAX8 Q06710 1/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 1/20 0.43
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7659521 1.00 MAPT (0.54) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL7656676 0.94 MAPT (0.49) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL7656683 0.94 MAPT (0.49) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL7661298 0.89 SMN1; SMN2 (0.56) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL7661372 0.89 SMN1; SMN2 (0.56) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL7657079 0.85 LMNA (0.52) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL7666320 0.84 LMNA (0.56) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL7666246 0.84 LMNA (0.56) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL8028001 0.84 MAPT (0.50) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL7657065 0.83 LMNA (0.52) MAPTALDH1A1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020111369-A1 Aryl sulfonic acids and derivatives as FSH antagonists AMERICAN HOME PRODUCTS CORPORATION (US) 2002-08-15 US claimed
WO-2000058277-A1 ARYL SULFONIC ACIDS AND DERIVATIVES AS FSH ANTAGONISTS AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-05 WO claimed
US-20020111369-A1 Aryl sulfonic acids and derivatives as FSH antagonists AMERICAN HOME PRODUCTS CORPORATION (US) 2002-08-15 US disclosed
US-6355633-B1 CONTRACEPTIVES AMERICAN HOME PRODUCTS CORPORATION 2002-03-12 US disclosed
WO-2000058277-A1 ARYL SULFONIC ACIDS AND DERIVATIVES AS FSH ANTAGONISTS AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020111369-A1 Aryl sulfonic acids and derivatives as FSH antagonists FSHR, GNRHR, LHCGR MAPT 4858/4885ALDH1A1 3990/4885LMNA 3330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.